How can age or disease affect pharmacokinetic parameters such as clearance and volume of distribution?

• A. Age or disease has no impact on clearance or Vd.
• B. Age or disease only affects half-life but not clearance.
• C. They randomly affect PK with no pattern.
• D. They can alter organ function and body composition; aging may reduce clearance; obesity can increase Vd for lipophilic drugs; children often have different Vd and CL.

Answer: (D)

Age and disease change how drugs move and are cleared because pharmacokinetics depends on the body’s organ function and body composition. Clearance reflects how quickly a drug is removed, mainly by the liver and kidneys, and aging often reduces hepatic metabolism and renal function, lowering clearance. The volume of distribution depends on where the drug goes in the body; aging can shift body composition (less total body water, changes in fat) and obesity increases fat mass, which raises the Vd for lipophilic drugs. In children, maturation of organ systems means they often have different clearance rates and distribution volumes compared with adults. Disease states further modify these parameters: liver disease can reduce metabolism, kidney disease can reduce excretion, and conditions with edema, ascites, or low albumin can increase the apparent Vd or change protein binding. Obesity is a classic case where Vd for lipophilic drugs increases, while aging may reduce clearance. This combination of altered organ function and body composition is exactly what drives the changes in clearance and volume of distribution, making the described pattern the best answer.